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Since the discovery andmolecular characterization of Ca2+-permeable AMPA channels just
over two decades ago, a large body of evidence has accumulated implicating contributions
of these unusual glutamate activated channels to selective neurodegeneration in certain
conditions, including ischemia and amyotrophic lateral sclerosis. Factors likely involved in
their contributions to disease include their distinct patterns of expression in certain neuronal
populations, their upregulation via various mechanisms in response to disease associated
stresses, and their high permeability to Zn2+ as well as to Ca2+. However, full characteriza-
tion of their contributions to certain diseases as well as development of therapeutics has
been limited by the lack of selective and bioavailable blockers of these channels that can
be employed in animals or humans. This review summarizes some of the clues that have
emerged over recent years to the contributions of these channels in disease.
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INTRODUCTION
Glutamate is the main excitatory transmitter in the mammalian
central nervous system. Overactivation of post-synaptic receptors
for glutamate places a metabolic stress upon neurons which can
contribute to neuronal injury in a wide range of conditions. The
evidence for a contribution of glutamate receptor overactivation
(termed “excitotoxicity”) is strongest in conditions like ischemia,
prolonged seizures, and trauma, in which there is rapid release
and extracellular accumulation of glutamate. However, there is
also compelling evidence for important excitotoxic contributions
to injury in neurodegenerative conditions including amyotrophic
lateral sclerosis (ALS).
Glutamate acts at a number of receptors comprising both lig-
and gated ion channels (ionotropic receptors) and g-protein linked
(metabotropic) receptors. Three families of ionotropic glutamate
receptors (NMDA, AMPA, and kainate receptors) have been char-
acterized both pharmacologically and by the identiﬁcation and
cloning of their subunit genes. Early studies of excitotoxic mech-
anisms focused on possible contributions of NMDA receptors,
which unlike most AMPA, and kainate receptors (collectively
referred to as AMPA/kainate receptors), are highly permeable
to Ca2+ ions, and brief activation of which could potently trig-
ger delayed injury to cultured neurons. However, despite clear
contributions of these channels in some models of acute neu-
rodegeneration, NMDA blockers have to date failed to show
impressive efﬁcacy in therapeutic trials. Furthermore, in some
studies AMPA/kainate receptor blockade has shown greater efﬁ-
cacy against ischemic injury than NMDA receptor antagonism
(Buchan et al., 1993).
Another early clue to contributions of AMPA/kainite in
neurodegeneration derives from studies of syndromes in
humans or primates linked to the consumption of envi-
ronmental toxins, beta-N -methylamino-l-alanine (BMAA),
beta-N -oxalylamino-l-alanine (BOAA), and domoic acid
(Spencer et al., 1986, 1987; Teitelbaum et al., 1990). BOAA and
domoic acid, the respective causes of lathyrism and a form of
shellﬁsh poisoning, are bothwell establishedAMPA/kainate recep-
tor agonists. BMAA, an unusual cyanobacterial toxin suspected of
contributing to forms of human neurodegenerative disease, can
induce selective injury to vulnerable subpopulations of neurons,
includingmotor neurons (MN,which degenerate inALS), via acti-
vation of AMPA/kainate receptors (Weiss et al., 1989; Weiss and
Choi, 1991; Rao et al., 2006). Whereas most AMPA/kainate type
glutamate channels are Ca2+ impermeable, subsets of these chan-
nels, which are expressed in characteristic temporal and spatial
patterns on discrete populations of neurons, are Ca2+-permeable,
and it is the activation of these channels that likely mediates most
of the neurodegeneration attributable to AMPA/kainate receptor
activation. This review focuses speciﬁcally on Ca2+-permeable
AMPA (Ca-AMPA) channels and clues that have accumulated
over the past two decades to their roles in both acute and chronic
neurodegenerative conditions.
STRUCTURE AND REGULATION OF Ca-AMPA CHANNELS
AMPA channels are the most prevalent glutamate channels in the
mammalian central nervous system, and mediate most routine
excitatory neurotransmission. They are tetramers comprised of
combinations of four subunits – GluA (previously referred to as
GluR) 1, 2, 3, or 4. The presence of one or more GluA2 subunits
in a heteromeric channel prevents Ca2+ permeability. The abil-
ity of GluA2 subunits to block Ca2+ permeability is dependent
upon the presence of a positively charged arginine residue at a
critical site in the channel lining region of the peptide (the “Q/R
site”); the other AMPA subunits (GluR1, 3, and 4) all have a neu-
tral glutamine at the homologous site. Interestingly, the genomic
DNA encodes a neutral glutamine residue at this site in all four
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subunits, and the arginine codon is post-transcriptionally inserted
into the GluA2 mRNA transcript via RNA editing by the enzyme
ADAR2 (Higuchi et al., 2000). After translation, the subunits are
assembled in the ER. Likely indicative of the critical importance of
these channels tonormal physiological function,channel assembly,
and membrane insertion are both sensitive to the editing state of
GluA2 (Greger et al., 2002, 2003; Araki et al., 2010). It has further
become apparent that pathological upregulation of these chan-
nels in disease states can occur via several mechanisms, including
downregulation of GluA2 mRNA transcription, defective editing
of the GluA2 pre-mRNA, and aberrant internalization of GluA2
containing (and Ca2+ impermeable) channels and insertion of
GluA2 lacking channels.
Thepresence of Ca-AMPAchannels is neither uniformnor con-
stant, but varies with cell type and developmental stage. Whereas
most adult neurons possess relatively few of these channels, dis-
crete populations of neurons,most prominently many GABAergic
inhibitory interneurons,possess largenumbers of Ca-AMPAchan-
nels (Jonas et al., 1994; Yin et al., 1994a; Leranth et al., 1996). In
contrast most adult excitatory pyramidal neurons possess few of
these channels. However, numbers of Ca-AMPA channels on pyra-
midal neurons change with developmental stage, and are present
in markedly increased numbers in both rats and humans in early
postnatal periods (Kumar et al., 2002; Talos et al., 2006a,b; Brill
and Huguenard, 2008).
MECHANISMS OF INJURY CAUSED BY Ca-AMPA CHANNELS
Asmentioned above, relatively brief but strong activation of highly
Ca2+ permeable NMDA channels is sufﬁcient to trigger degener-
ation of cultured neurons. A large number of studies have high-
lighted mechanisms through which such neuronal Ca2+ loading
can induce injury, which may vary depending upon the intensity
of the Ca2+ load.With strong loading, Ca2+ is taken up intomito-
chondria and can disrupt their function, causing release of damag-
ing reactive oxygen species (ROS; Dugan et al., 1995; Reynolds and
Hastings,1995). In addition,Ca2+ loading can induceROSgenera-
tion through other mechanisms, including the activation of nitric
oxide synthetase (NOS), with resultant nitric oxide production,
and the activation of NADPH-oxidase, with resultant superox-
ide production (Dawson et al., 1991; Brennan et al., 2009). These
ROS may induce DNA damage, causing activation of the enzyme,
PARP, which can injure neurons via NAD+ depletion, resulting
in glycolytic block, depletion of ATP, and induction of apoptotic
signaling via release of AIF from mitochondria (Hong et al., 2004;
Alano et al., 2010).
It appears likely that many of these same downstream mecha-
nismsmay apply to injury causedby strong activationof Ca-AMPA
channels (Carriedo et al., 1998). A key question thus concerns dif-
ferences between NMDA and Ca-AMPA dependent injury, possi-
bly accounting for the apparent greater contributions of Ca-AMPA
channels in some conditions. One difference is that NMDA chan-
nels are subject to a voltage dependent block of their pores by
extracellular Mg2+ ions, such that there is relatively little ion ﬂux
through these channels in the absence of signiﬁcant post-synaptic
depolarization. This voltage dependence allows NMDA channels
to detect temporally and spatially convergent post-synaptic inputs
and is thus important to their roles in activity dependent synaptic
plasticity. In contrast,Ca-AMPAchannels are not blockedby extra-
cellular cations (but are subject to voltage dependent block by
intracellular polyamines, resulting in inwardly rectifying currents),
and thus freely permit Ca2+ entry with any level of receptor acti-
vation. Secondly, whereas the expression of NMDA channels is
relatively static,AMPA channels are strongly regulated in response
to physiological and pathological signals, and numbers of Ca-
AMPA channels may increase sharply in certain stress conditions
and disease states (as discussed further below). Thus, the increase
in numbers of these channels in already stressed neurons adds
an additional metabolic burden that may impair their ability to
restore homeostasis and survive.
A likely third factor in their propensity to contribute to injury
concerns their permeability to other divalent cations. Zn2+ is
present in pre-synaptic vesicles of many (but not all) forebrain
excitatory pathways, and appears to be co-released with glutamate
upon pre-synaptic activation (Assaf and Chung, 1984; Howell
et al., 1984; Qian and Noebels, 2005). Although the physiological
signiﬁcance of pre-synaptic Zn2+ release is uncertain, it can effec-
tively block NMDA channels, limiting their ion ﬂux in response to
intense pre-synaptic activation (Paoletti et al., 2009). In contrast,
Zn2+ readily permeates Ca-AMPA channels (Jia et al., 2002), and
its entry through these channels can clearly injure cultured neu-
rons and likely contributes to injury in conditions like ischemia
(Yin andWeiss, 1995; Sensi et al., 1999; Yin et al., 2002; Calderone
et al., 2004; Noh et al., 2005). Intracellular Zn2+ can trigger neu-
rodegeneration via a number of mechanisms, including some
previously attributed to Ca2+, including the induction of mito-
chondrial dysfunction, which it appears to do with considerably
greater potency than Ca2+ (Sensi et al., 2009; Shuttleworth and
Weiss, 2011).
Ca-AMPA CHANNELS IN ISCHEMIC NEURODEGENERATION
As mentioned above, some early studies found AMPA/kainate
blockers to provide greater protection than NMDA blockers
against ischemic neurodegeneration, and it is likely that much
of this protection reﬂects blockade of Ca-AMPA channels. Studies
to date have suggested that Ca-AMPA channels may contribute to
different forms of ischemic injury in a number of ways.
The immature brain is particularly susceptible to ischemia, and
pre-term, or perinatal hypoxia ischemia of both white and gray
matter is a major cause of early life morbidity, for instance as
an antecedent of cerebral palsy. A number of studies have indi-
cated that periods of high ischemic susceptibility correspond to
developmental periods of increased Ca-AMPA channel numbers,
suggesting that the presence of these channels contributes to the
ischemic susceptibility (Talos et al., 2006a,b).
Transient global ischemia (TGI), as occurs in cardiac arrest,
causes a variable degree of neuronal damage and loss, depending
upon the duration of the ischemia. In hippocampus, pyramidal
neurons (HPNs) in the CA1 subﬁeld are particularly susceptible.
Although adult HPNs were previously felt to lack Ca-AMPA chan-
nels, especially in contrast to strongly Ca-AMPA channel express-
ing GABAergic interneurons, a number of studies have suggested
that they may often be present under basal conditions in relatively
low numbers, and preferentially on dendrites at a distance from
the somawhere they are not readily detected electrophysiologically
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(Lerma et al., 1994; Ikonomovic et al., 1995;Yin et al., 1999;Ogoshi
andWeiss, 2003).
In speciﬁc support of a role for Ca-AMPA channels in ischemic
injury,maneuvers to increase numbers of these channels increased
susceptibility of CA1 pyramidal neurons to ischemic injury,
whereas decreasing channel numbers decreased injury (Anzai
et al., 2003; Liu et al., 2004). A very intriguing clue to con-
tributions of Ca-AMPA was provided by the observation that
transient ischemia could induce a selective downregulation of
GluA2 mRNA in CA1 pyramidal neurons, resulting in a delayed
(after 2–3 days) incorporation of increased numbers Ca-AMPA
channels into synapses (Gorter et al., 1997; Pellegrini-Giampietro
et al., 1997; Grooms et al., 2000; Opitz et al., 2000). Further-
more, indicating a direct role of these channels in the delayed
neurodegeneration of CA1 neurons, the injury was attenuated by
the delayed administration of a Ca-AMPA channel blocker (Noh
et al., 2005).
Further studies point toward intriguing roles of Zn2+ in
this form of injury. First, highlighting contributions of Zn2+
to ischemic neurodegeneration, Zn2+ accumulates in degenerat-
ing neurons and injury was attenuated by an extracellular Zn2+
chelator (Tonder et al., 1990; Koh et al., 1996). Supporting a con-
tribution of Zn2+ entry through Ca-AMPA channels, either an
extracellular Zn2+ chelator or a Ca-AMPA channel blocker atten-
uated neuronal Zn2+ accumulation and subsequent degeneration
in a hippocampal slice model of ischemia (Yin et al., 2002). Inter-
estingly, Zn2+ may act in distinct ways during different temporal
phases of the ischemic process. Addition of an extracellular Zn2+
chelator before the ischemic episode attenuated the GluA2 down-
regulation, preventing the delayed increase in Ca-AMPA channels
(Calderone et al., 2004). A number of recent studies suggest that
mitochondria might be an important target of these early Zn2+
rises (Calderone et al., 2004; Bonanni et al., 2006;Medvedeva et al.,
2009). These acute events appear to result in upregulation of the
gene silencing transcription factor neuronal repressor element-1
silencing transcription factor (REST)/neuron-restrictive silencer
factor (NRSF), which has been linked to the delayed downregula-
tion of GluA2 (Calderone et al., 2003). In contrast, late addition
of either the chelator or of a Ca-AMPA channel blocker, after the
channel upregulation was already underway, attenuated the occur-
rence of a delayed intracellular Zn2+ rise and associated cell death
(Calderone et al., 2004; Noh et al., 2005), consistent with the idea
that Zn2+ entry through the newly inserted channels might con-
tribute to the delayed injury. Of note, however, it is clear that not
all ischemic Zn2+ accumulation reﬂects entry through Ca-AMPA
or other channels, and that there are stores of Zn2+ already present
in the CA1 neurons which can bemobilized in response to acidosis
and oxidative stress associated with ischemia, contributing to the
rises (Aizenman et al., 2000; Lee et al., 2000).
Whereas downregulation of GluA2 results in the incorporation
of new Ca-AMPA channels after a signiﬁcant delay, other recent
studies have suggested that ischemia can also induce a more rapid
endocytosis of Ca2+ impermeable AMPA channels and exocyto-
sis of Ca-AMPA channels into synapses via mechanisms involving
receptor trafﬁcking events that may be involved in synaptic plas-
ticity (Liu et al., 2006; Dixon et al., 2009). Another study suggested
that defects in GluA2 editing may occur after ischemia, resulting
in the incorporation of unedited GluA2 into channels, render-
ing them Ca2+ permeable (Peng et al., 2006). Interestingly, AMPA
receptors containing unedited GluA2 may be particularly toxic to
neurons, in part because of their constitutive trafﬁcking to the
plasma membrane (Mahajan and Ziff, 2007).
Ca-AMPA CHANNELS IN ALS
Amyotrophic lateral sclerosis is a neurodegenerative disease char-
acterized by progressive weakness due to the relatively selective
degeneration of upper and lower MNs, usually leading to death
within 2–5 years of diagnosis. Whereas most cases are sporadic,
∼10% are familial, and of those a fraction are linked to dom-
inant mutations in the gene superoxide dismutase 1 (SOD1).
Observations of loss of the ability of astrocytes to take up extracel-
lular glutamate provided an early clue that excitotoxicity might
contribute to the MN injury. Consistent with this idea, gluta-
mate uptake blockers caused preferential loss of MNs both in
organotypic slice and dissociated culture models (Rothstein et al.,
1993; Carriedo et al., 1996). Furthermore, supporting a role of
AMPA/kainate receptors in the disease, this MN degeneration was
prevented by AMPA/kainate blockers, but not by NMDA blockers.
We and others have investigated mechanisms underlying the
excitotoxic vulnerability of MNs. First, they possess substantial
numbers of Ca-AMPA channels (Carriedo et al., 1996; Van Den
Bosch et al., 2000; Vandenberghe et al., 2000). In addition, pop-
ulations of MNs that degenerate in ALS are characterized by
having low levels of cytosolic Ca2+ buffering proteins (Alexianu
et al., 1994; Elliott and Snider, 1995), and buffer cytosolic Ca2+
loads poorly (Vanselow and Keller, 2000), such that excitotoxically
induced Ca2+ loads are rapidly taken up into the mitochon-
dria,with consequent strongmitochondrial ROS release (Carriedo
et al., 2000). In further studies, we have found evidence that this
mitochondrial ROSmight not only damage theMNs, but also exit
the MNs and contribute to the loss or dysfunction of glutamate
transporters on surrounding astrocytes (Rao et al., 2003). Such a
mechanismmight contribute to the propagation of a feed forward
cascade, with loss of glutamate transport resulting in increased
extracellular glutamate levels, more activation of Ca-AMPA chan-
nels, andmoremitochondrial Ca2+ loading resulting inmore ROS
generation (Rao andWeiss, 2004; Yin et al., 2007).
Transgenic mice overexpressing familial ALS associated SOD1
mutations have provided by far the most studied animal models
of the disease. Providing strong evidence that Ca-AMPA channels
play a role in this form of the disease, generation of SOD1 mutant
mice with increased numbers of Ca-AMPA channels in their MNs
accelerates disease progression, while decreasing numbers of the
channels in thesemice slows the disease (Tateno et al., 2004; Kuner
et al., 2005; Van Damme et al., 2005).
In addition to thepresence of someCa-AMPAchannels onMNs
under basal conditions, an intriguing series of studies suggests that
there may be a loss of GluA2 editing in ALS MNs, such that num-
bers of Ca-AMPA channels may increase, further predisposing
them to injury (Kawahara et al., 2004; Kwak et al., 2010). As men-
tioned above,AMPA receptors containing unedited GluA2may be
particularly effective at inducing neurotoxicity (Mahajan and Ziff,
2007). Another recent study suggests that the loss of GluA2 edit-
ing may be triggered as a consequence of excitotoxic exposures,
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via proteolytic cleavage of the editing enzyme, RNA-dependent
adenosine deaminase, ADAR2 (Mahajan et al., 2011).
Ca-AMPA CHANNELS IN OTHER CONDITIONS
Although roles of Ca-AMPA channels have been most studied in
the cases of ischemia and ALS, there are compelling clues to con-
tributions in other conditions as well. First, Ca-AMPA channels
may well contribute to neurodegeneration in conditions of pro-
longed seizures, or brain, or spinal cord trauma,both of which, like
ischemia are associated with prolonged elevations of extracellular
glutamate. Much as in ischemia, GluA2 mRNA, and protein lev-
els have been observed to decrease following prolonged seizures
in CA1 and CA3 hippocampal pyramidal neurons prior to the
death of these cells (Friedman et al., 1994; Grooms et al., 2000). In
the case of traumatic injury, ventral root avulsion induced loss of
GluA2 in spinal MNs (Nagano et al., 2003) and spinal cord contu-
sion caused preferential loss of GluA2 in MNs that persisted for at
least a month (Grossman et al., 1999). In addition, recent studies
in models of cerebral trauma provide evidence for endocytosis of
GluA2 containing receptors and insertion of Ca-AMPA receptors
that contributed to the induction of injury (Spaethling et al., 2008;
Bell et al., 2009).
Other studies suggest possible contributions of Ca-AMPA
channels to neurodegeneration in Alzheimer’s disease. Cholin-
ergic neurons of the basal forebrain conspicuously degenerate
in Alzheimer’s disease (Whitehouse et al., 1982), and there is
evidence for loss of other subpopulations of interneurons includ-
ing those containing parvalbumin or somatostatin (Davies et al.,
1980; Rossor et al., 1980; Arai et al., 1987). Interestingly, in vitro
studies indicate that these populations are all selectively sensi-
tive to AMPA/kainate receptor mediated excitotoxicity, probably
in large part due to their possession of substantial numbers of
Ca-AMPA channels (Weiss et al., 1990, 1994; Yin et al., 1994b).
Other studies have found GluA2 on basal forebrain cholinergic
neurons to be markedly decreased in aged humans (Ikonomovic
et al., 2000), and that levels of GluA2 on pyramidal neurons
in the entorhinal cortex and hippocampus of Alzheimer brains
decrease prior to neuroﬁbrillary tangle formation (Ikonomovic
et al., 1997), suggesting that increased numbers of Ca-AMPA
channels may predispose to the degeneration of these neuronal
populations.
Further intriguing studies suggest a link between inﬂammation
and increases in Ca-AMPA channel numbers. The inﬂammatory
cytokine, tissue necrosis factor-alpha (TNF-α) can lead to rapid
exocytosis of Ca-AMPA channels on pyramidal neurons (Beat-
tie et al., 2002; Ogoshi et al., 2005; Stellwagen et al., 2005), and
recent studies strongly suggest that TNF-α dependent trafﬁck-
ing of Ca-AMPA channels contributes to neurodegeneration after
spinal cord trauma (Ferguson et al., 2008). This mechanism could
prove relevant to neurodegeneration in other immune or neu-
rodegenerative conditions inwhich acute or chronic inﬂammation
occurs.
CONCLUSIONS
The past two decades have seen the accumulation of a host of
clues to contributions of Ca-AMPA channels in a wide range
of diseases of the nervous system. The presence of Ca-AMPA
channels is not felt to be causative of the diseases. But the pref-
erential expression of Ca-AMPA channels on subpopulations of
neurons may be a factor in the selective patterns of neurode-
generation seen in certain conditions. In addition, the propensity
for the upregulation of Ca-AMPA channel numbers, likely via a
range of mechanisms, in response to disease associated signals
may well subject affected neurons to new stresses that may tip
the balance toward degeneration. Despite the accumulation of
numerous clues to roles of Ca-AMPA channels in disease, many
questions, and obstacles exist. There are as yet no proven thera-
peutics based on the modulation or block of these channels. This
likely reﬂects the absence to date of any highly effective, selec-
tive, and bioavailable drugs for blocking Ca-AMPA channels in
whole animals, as would be necessary to fully test their contribu-
tions to disease. Such blockers, if available, might be remarkably
useful neuroprotectants in a wide range of conditions, as they
may effectively antagonize toxic Ca2+ and Zn2+ entry through
these channels without overly suppressing overall glutamatergic
neurotransmission.
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